DERMAGO receives 2 million euros by private investor network.
Via Companisto, more than 750 private investors participate in the financing of the pharmaceutical company with international sales and distribution.
Berlin, 28 June 2022
In the financing round on Companisto, the pharmaceutical company DERMAGO GmbH received an investment commitment of just under 2 million euros within only a few weeks. More than 750 private investors participated in the pharmaceutical company, which has already launched 2 out of 3 reimbursable pharmaceuticals for international distribution on the market.
The pharmaceutical company has been developing and marketing generics for prescription medicines in the field of skin diseases. In addition, the company also has a patent-protected originator product in the same field.
By investing in DERMAGO GmbH, the investors had the opportunity to make investments in three pharmaceutical companies at the same time with DERMAGO GmbH acting as the parent company of its subsidiaries Aresus Pharma, DEGODE Pharma and Skin Care Pharma. Both DEGODE Pharma and Aresus Pharma are no strangers to the private investor network.
Already in 2018, DEGODE Pharma completed a successful financing round on Companisto. In 2019, Aresus Pharma followed suit and was also able to successfully complete the round.
In 2021, the parent company was founded to create synergy effects in the areas of distribution, administration, development as well as quality management and was carried out with the support of Companisto. The funds from the current financing round are to be used both for sales expansion and for the clinical study of a new indication.
Owing to the investment round on Companisto, the pharmaceutical company was also able to gain additional active supporters for the further development of the startup.
Along with many other relevant industries, investors from the health care and pharmaceutical industries can be found in the Companisto private investor network, who are supporting DERMAGO in its further growth.
Press release – Companisto – DERMAGO GmbH financing round
COMPANISTO
Sven Schimansky-Wabra, founder and general manager of DERMAGO GmbH, commented on the successfully completed financing round on Companisto: “I am really pleased that we have completed another successful financing round with Companisto and would like to thank our investors for the trust they have vested in us.
We will make good use of the funds to advance the clinical development of our products and provide patients and physicians with new treatment options”.
About DERMAGO
DERMAGO GmbH is a service company that has been specializing in the development of unique generic versions and originator preparations of prescription, reimbursable dermatological pharmaceuticals and in independently advancing these through the pharmaceutical approval process.
The services of DERMAGO GmbH also include consulting activities, scientific assessments, the preparation of expert reports as well as qualitative and quantitative studies especially for dermatological pharmaceuticals.
The development of analytical methods and procedures as well as services for obtaining marketing authorization for pharmaceutical products are also part of the range of the company’s activities.
About Companisto
Companisto is the market-leading private investor network in the D-A-CH region (Germany, Austria and Switzerland) and has been the most active private venture capital provider in Germany for five years in a row.
Over 152 million euros have been committed via Companisto to date in currently 230 financing rounds. Since 2018, Companisto has expanded its network of at present 124,000 private investors with a digitally organized Business Angel Club. Some 1,400 business angels invest in the equity of companies via Companisto with investments starting at 10,000 euros.
The investment process and management of participations have been fully digitalized.
Further information
www.companisto.com, www.companisto.com/de/angel-club, www.dermago-group.com
Contact partner
presse@companisto.com
Companisto GmbH | Köpenicker Str. 154 | 10997 Berlin
Press release – Companisto – DERMAGO GmbH financing round